Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 1011
interventional 873
Observational 131
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Behavioral 479
Drug 120
Drug|placebo 87
Other 68
Behavioral|Other 27
Device 24
Behavioral|Drug 16
Drug|Other 12
Procedure 8
Behavioral|Drug|placebo 7
Behavioral|placebo 6
Device|Drug 3
Behavioral|Biological 2
Behavioral|Device 2
Device|Other 2
Dietary Supplement|placebo 2
Behavioral|Device|Drug 1
Behavioral|Procedure 1
Biological|Drug 1
Device|Drug|Other 1
Device|Drug|placebo 1
Dietary Supplement 1
Drug|Other|placebo 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 692
NA 45
Canada 25
Norway 13
Switzerland 11
United Kingdom 9
Sweden 8
Spain 6
India 5
Brazil 4
Germany 4
Netherlands 4
South Africa 4
Austria 2
China 2
Finland 2
France 2
Puerto Rico 2
Taiwan 2
Turkey 2
United States|Kazakhstan 2
United States|South Africa 2
Vietnam 2
Zambia 2
Australia 1
Belgium 1
Botswana 1
Chile 1
Colombia 1
Denmark 1
Germany|Switzerland 1
Italy 1
Kazakhstan 1
Kenya 1
Korea, Republic of 1
Kosovo 1
Mexico 1
Russian Federation 1
United States|Australia|Denmark|Germany|Hungary|Sweden|Taiwan|United Kingdom 1
United States|Canada 1
United States|Czechia 1
United States|Estonia 1
United States|Malaysia 1
United States|Puerto Rico 1
United States|Ukraine 1

Sites per Study

Site_count Study_Count
1 692
2 85
3 22
4 16
5 10
6 9
7 5
8 4
9 3
10 4
11 3
12 7
13 1
14 1
16 1
20 2
24 1
30 1
32 1
36 1
39 2
42 1
49 1

Phase

Phase Study_Count
N/A 496
Phase 2 118
Phase 1 91
Phase 4 55
Phase 3 54
Phase 1/Phase 2 27
Phase 2/Phase 3 21
Early Phase 1 11

Number of Arms

Number_of_Arms Count_of_Studies
1 110
2 510
3 94
4 40
5 12
6 8
7 3
8 3
16 1
NA 92

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 24.0 3.0000 0.00000 20.0000 0.000 28.0000 0.0000 0.0000
1st Qu. 40.0 60.0000 16.00000 83.0000 18.500 121.0000 169.7500 23.0000
Median 49.0 126.0000 35.00000 131.0000 68.000 141.0000 311.5000 75.0000
Mean 60.0 889.4606 70.59341 171.5556 115.513 760.6667 355.2407 184.2264
3rd Qu. 75.5 360.0000 80.00000 206.0000 160.000 678.0000 458.7500 188.0000
Max. 131.0 175000.0000 641.00000 610.0000 1030.000 7695.0000 1281.0000 2000.0000

Trial Group Type

group_type Group_Count
Experimental 877
Active Comparator 451
No Intervention 175
Placebo Comparator 138
NA 92
Other 82
Sham Comparator 18

Intervention Model

intervention_model Study_Count
Parallel Assignment 583
Single Group Assignment 127
Crossover Assignment 77
NA 43
Factorial Assignment 41
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 518
Prevention 126
Health Services Research 69
Basic Science 39
NA 38
Other 34
Supportive Care 27
Screening 13
Diagnostic 8
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 83
NA 17
France 5
Norway 5
China 3
Switzerland 3
Canada 2
Germany 2
Hong Kong 2
Mexico 2
United Kingdom 2
Austria 1
Netherlands 1
Senegal 1
United States|Puerto Rico 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 111
2 13
3 2
4 1
5 1
7 2
11 1

Enrollment Metrics

Measure Observational
Min 6.00
1st Qu 89.75
Median 245.50
Mean 12763.63
3rd Qu 821.00
Max 646620.00

Observation Model

observational_model Study_Count
Cohort 52
NA 26
Other 18
Case-Control 13
Case-Only 10
Case Control 4
Ecologic or Community 4
Family-Based 2
Case-Crossover 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 74
Cross-Sectional 24
Retrospective 14
Other 12
NA 7

Registries

Studies by Country

Country Study_Count
United States 3
Norway 2
Sweden 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 7

Enrollment Metrics

Measure Registries
Min 81.000
1st Qu 150.500
Median 200.000
Mean 5054.571
3rd Qu 4900.000
Max 25000.000

Registry Model

observational_model Study_Count
Cohort 4
Other 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 6
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Year 1
10 Years 1
12 Months 1
2 Years 1
25 Years 1
30 Days 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00787423 Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population https://ClinicalTrials.gov/show/NCT00787423 Completed National Institutes of Health Clinical Center (CC) NA
NCT04067076 Massive Mental Health Screening Using Smartphones in 24 Pre-graduate Education Centers in Mexico City: TEDUCA Survey Protocol https://ClinicalTrials.gov/show/NCT04067076 Recruiting Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 2020-07-31
NCT04067063 Population Screening Using Smartphone in Milpa Alta https://ClinicalTrials.gov/show/NCT04067063 Recruiting Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 2021-01-23
NCT03260075 Effects of Ward Cats in Patients With Substance Abuse, Depression and Psychosis at UPK Basel https://ClinicalTrials.gov/show/NCT03260075 Completed Swiss Tropical & Public Health Institute 2017-12-15
NCT03237650 Conditioned Pain Modulation Using Painful Cutaneous Electrical Stimulation or Simply Habituation? https://ClinicalTrials.gov/show/NCT03237650 Completed Ruhr University of Bochum 2016-09-30
NCT03131505 INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 https://ClinicalTrials.gov/show/NCT03131505 Completed Norfolk and Suffolk NHS Foundation Trust 2017-12-01
NCT02986841 A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (“CDE-EHR-PC” Study), Phase 2 https://ClinicalTrials.gov/show/NCT02986841 Completed NYU Langone Health 2018-09-01
NCT02981849 Validating Adolescent SBIRT Measures https://ClinicalTrials.gov/show/NCT02981849 Completed Boston Children’s Hospital 2019-03-31
NCT02950376 The Novel Addiction Assessment Study in Synthetic Drugs Addiction https://ClinicalTrials.gov/show/NCT02950376 Completed Shanghai Mental Health Center 2018-12-31
NCT02930577 Treatment Adherence in Substance Users https://ClinicalTrials.gov/show/NCT02930577 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2016-05-31
NCT02861820 Functional Connectivity Changes During Early Recovery as a Marker for Relapse https://ClinicalTrials.gov/show/NCT02861820 Recruiting University of Minnesota 2020-06-30
NCT02797990 Conflict Between Maternal Autonomy and Child Health in Substance-use https://ClinicalTrials.gov/show/NCT02797990 Completed London School of Hygiene and Tropical Medicine 2016-08-31
NCT02751762 A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain https://ClinicalTrials.gov/show/NCT02751762 Recruiting Member Companies of the Opioid PMR Consortium 2020-10-31
NCT02678507 A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire https://ClinicalTrials.gov/show/NCT02678507 Completed Member Companies of the Opioid PMR Consortium 2017-06-21
NCT02668549 Cross-Sectional Study to Define and Validate “Doctor/Pharmacy Shopping” as Outcomes Suggestive of Abuse and/or Addiction https://ClinicalTrials.gov/show/NCT02668549 Completed Member Companies of the Opioid PMR Consortium 2017-08-09
NCT02667262 An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data https://ClinicalTrials.gov/show/NCT02667262 Completed Member Companies of the Opioid PMR Consortium 2017-05-17
NCT02667210 Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review https://ClinicalTrials.gov/show/NCT02667210 Completed Member Companies of the Opioid PMR Consortium 2017-06-21
NCT02667197 Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B https://ClinicalTrials.gov/show/NCT02667197 Completed Member Companies of the Opioid PMR Consortium 2017-05-17
NCT02667158 A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion https://ClinicalTrials.gov/show/NCT02667158 Completed Member Companies of the Opioid PMR Consortium 2018-12-19
NCT02660619 Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication https://ClinicalTrials.gov/show/NCT02660619 Completed Member Companies of the Opioid PMR Consortium 2017-11-28
NCT02660606 A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire https://ClinicalTrials.gov/show/NCT02660606 Completed Member Companies of the Opioid PMR Consortium 2016-01-18
NCT02621411 Observational Study of Preoperative Screen for Substance Abuse https://ClinicalTrials.gov/show/NCT02621411 Completed West China Hospital 2016-12-31
NCT02601495 Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery https://ClinicalTrials.gov/show/NCT02601495 Active, not recruiting Laureate Institute for Brain Research, Inc. 2020-11-30
NCT02583243 Project BEST: Buprenorphine Entry Into Substance Abuse Treatment https://ClinicalTrials.gov/show/NCT02583243 Completed Yale University 2008-08-31
NCT01571752 Health Outcomes by Neighborhood - Baltimore https://ClinicalTrials.gov/show/NCT01571752 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01036685 Cognitive Task Development and Implementation for Functional MRI Studies https://ClinicalTrials.gov/show/NCT01036685 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02573948 Feasibility of Interventions on People Who Inject Drugs in Vietnam https://ClinicalTrials.gov/show/NCT02573948 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2015-06-30
NCT02450240 Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders https://ClinicalTrials.gov/show/NCT02450240 Completed Laureate Institute for Brain Research, Inc. 2020-06-30
NCT01148381 Characterization of Phenotypic and Genotypic Regressors for Imaging https://ClinicalTrials.gov/show/NCT01148381 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02525731 Targeting Effective Analgesia in Clinics for HIV - Patient Cohort https://ClinicalTrials.gov/show/NCT02525731 Completed Boston Medical Center 2018-11-30
NCT02503618 Understanding Substance Use and Incident HIV/STI Among Young Black MSM https://ClinicalTrials.gov/show/NCT02503618 Completed Emory University 2019-03-18
NCT02476877 A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse https://ClinicalTrials.gov/show/NCT02476877 Completed Advanced Clinical Laboratory Solutions, Inc. 2016-01-31
NCT02438254 Texas Family Health Patterns: A Study Across Generations https://ClinicalTrials.gov/show/NCT02438254 Completed The University of Texas Health Science Center at San Antonio 2016-09-30
NCT02433496 Physician Coaching to Reduce Opioid-related Harms https://ClinicalTrials.gov/show/NCT02433496 Completed University of Wisconsin, Madison 2017-06-30
NCT02299921 Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT02299921 Active, not recruiting University of Colorado, Denver 2022-02-28
NCT02244138 Improving Adolescent Health Outcomes Through Preventive Care Transformation https://ClinicalTrials.gov/show/NCT02244138 Completed Indiana University 2017-09-30
NCT02225184 Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans https://ClinicalTrials.gov/show/NCT02225184 Completed National Institutes of Health Clinical Center (CC) 2018-12-31
NCT02224508 Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks https://ClinicalTrials.gov/show/NCT02224508 Completed Kaiser Permanente 2016-01-31
NCT01984177 Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence https://ClinicalTrials.gov/show/NCT01984177 Completed Centre for Addiction and Mental Health 2016-06-30
NCT01863290 Linking Former Inmates to Primary Care https://ClinicalTrials.gov/show/NCT01863290 Completed Yale University 2016-05-31
NCT01847729 OPAL: “Opiates and PhArmacoLogy” https://ClinicalTrials.gov/show/NCT01847729 Completed Nantes University Hospital 2016-07-21
NCT01816958 Neuromodulation to Facilitate the Effect of Ketamine https://ClinicalTrials.gov/show/NCT01816958 Completed The Neuroscience Center, LLC 2012-11-30
NCT01740115 Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort https://ClinicalTrials.gov/show/NCT01740115 Completed Boston Medical Center 2016-03-31
NCT01722006 Drug Effects on Preference and Reward https://ClinicalTrials.gov/show/NCT01722006 Completed University of Chicago 2012-07-31
NCT01661478 Healthcare Provider Attitudes Towards Patients With Substance Use Before and After Implementation of the SBIRT Model in the Emergency Room https://ClinicalTrials.gov/show/NCT01661478 Completed University of Alabama at Birmingham NA
NCT01621607 Individual Differences in Reward and Impulse Control https://ClinicalTrials.gov/show/NCT01621607 Completed National Institutes of Health Clinical Center (CC) NA
NCT01545778 Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR) https://ClinicalTrials.gov/show/NCT01545778 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2012-02-29
NCT04440098 Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology https://ClinicalTrials.gov/show/NCT04440098 Completed University of Miami 2020-05-11
NCT04405414 EffectS of CAnnabidiol in Patients: Evaluation https://ClinicalTrials.gov/show/NCT04405414 Recruiting Nantes University Hospital 2021-05-20
NCT04343339 Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment https://ClinicalTrials.gov/show/NCT04343339 Recruiting University Hospital, Montpellier 2020-07-30
NCT04308655 Obstetric Pain Management for Women With Opioid Use Disorder (QUEST) https://ClinicalTrials.gov/show/NCT04308655 Recruiting University of Pittsburgh 2021-03-06
NCT04301024 Nitrous Oxyde Misuse Among Teenagers Consulting in an Addictology Center Dedicated to Young Drug Users in Montpellier https://ClinicalTrials.gov/show/NCT04301024 Recruiting University Hospital, Montpellier 2020-06-30
NCT04251208 MOms in REcovery (MORE) Study: Defining Optimal Care https://ClinicalTrials.gov/show/NCT04251208 Recruiting Trustees of Dartmouth College 2021-10-31
NCT04185896 Perinatal Mental Health Care in Switzerland https://ClinicalTrials.gov/show/NCT04185896 Recruiting Bern University of Applied Sciences 2020-02-29
NCT04162132 Contingency Management Using Smartphone App in Patients With SUD https://ClinicalTrials.gov/show/NCT04162132 Completed BrightView LLC 2019-07-29
NCT04141202 Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder https://ClinicalTrials.gov/show/NCT04141202 Recruiting St. Olavs Hospital 2023-02-28
NCT04138459 Recovery - a Collaborative Project https://ClinicalTrials.gov/show/NCT04138459 Recruiting University College of Southeast Norway 2020-12-15
NCT04132557 A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine https://ClinicalTrials.gov/show/NCT04132557 Completed Janssen Research & Development, LLC 2019-10-25
NCT04105621 Westlake Personalized Nutrition and Health Cohort for Drug Addicts https://ClinicalTrials.gov/show/NCT04105621 Recruiting Westlake University 2020-11-30
NCT04096001 Woebot for Substance Use Disorders https://ClinicalTrials.gov/show/NCT04096001 Recruiting Woebot Labs, Inc. 2020-06-01
NCT04063839 HCV Treatment in a Low-threshold Clinic https://ClinicalTrials.gov/show/NCT04063839 Recruiting University Hospital, Akershus 2019-10-31
NCT04048850 Zepatier in Patients With Substance Use https://ClinicalTrials.gov/show/NCT04048850 Enrolling by invitation University of Illinois at Chicago 2020-08-01
NCT03947749 Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain https://ClinicalTrials.gov/show/NCT03947749 Recruiting University of Florida 2022-06-30
NCT03936985 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool https://ClinicalTrials.gov/show/NCT03936985 Recruiting University of Utah 2020-08-30
NCT03932188 Brain Imaging in Early Psychosis https://ClinicalTrials.gov/show/NCT03932188 Recruiting Washington University School of Medicine 2021-04-30
NCT03913819 Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction https://ClinicalTrials.gov/show/NCT03913819 Recruiting Chinese University of Hong Kong 2020-12-31
NCT03758053 Adverse Childhood Experiences in Substance-related Disorders https://ClinicalTrials.gov/show/NCT03758053 Recruiting Central Institute of Mental Health, Mannheim 2021-03-31
NCT03753737 Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population https://ClinicalTrials.gov/show/NCT03753737 Completed Hospices Civils de Lyon 2019-04-29
NCT03745339 Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder https://ClinicalTrials.gov/show/NCT03745339 Recruiting National Institutes of Health Clinical Center (CC) 2021-10-01
NCT03628846 Opioid Use After Traumatic Injury in Adolescents https://ClinicalTrials.gov/show/NCT03628846 Recruiting Indiana University 2021-12-31
NCT03623178 Assertive Community Treatment for Patients Suffering From Substance Use Disorders https://ClinicalTrials.gov/show/NCT03623178 Recruiting University Hospital, Geneva 2019-01-01
NCT03583138 HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) https://ClinicalTrials.gov/show/NCT03583138 Completed Yale University 2015-12-15
NCT03566459 Medications for Opioid Use Disorders (MOUD) Via Telemedicine https://ClinicalTrials.gov/show/NCT03566459 Completed VA Office of Research and Development 2019-03-31
NCT03560076 Implementation and Evaluation of SBIRT https://ClinicalTrials.gov/show/NCT03560076 Completed Indiana University 2019-07-31
NCT03554928 Longitudinal Assessment of Functional Connectivity in Treatment Engaged Cocaine Users https://ClinicalTrials.gov/show/NCT03554928 Completed Medical University of South Carolina 2019-06-09
NCT03544112 Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder https://ClinicalTrials.gov/show/NCT03544112 Completed NYU Langone Health 2019-05-29
NCT03486028 Patient Centered Assessment and Substance Use Disorder Treatment Study (PCAST) https://ClinicalTrials.gov/show/NCT03486028 Completed RTI International 2019-09-01
NCT03485339 Substance Misuse To Psychosis for Ketamine (SToP-K) https://ClinicalTrials.gov/show/NCT03485339 Active, not recruiting The University of Hong Kong 2020-06-05
NCT03459768 Cohort Study on People Who Inject Drugs in Senegal https://ClinicalTrials.gov/show/NCT03459768 Active, not recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2020-02-29
NCT03434457 Maternal Adversity, Vulnerability and Neurodevelopment https://ClinicalTrials.gov/show/NCT03434457 Completed Douglas Mental Health University Institute 2017-12-01
NCT03422211 A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries https://ClinicalTrials.gov/show/NCT03422211 Active, not recruiting St. Louis University 2018-11-06
NCT01093898 The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse https://ClinicalTrials.gov/show/NCT01093898 Completed Dartmouth-Hitchcock Medical Center 2014-05-31
NCT01037569 Optimizing Toxicological Screening in Drug Endangered Children https://ClinicalTrials.gov/show/NCT01037569 Completed National Institutes of Health Clinical Center (CC) NA
NCT01037153 Effects of Nicotine on Brain Activity as Measured by fMRI https://ClinicalTrials.gov/show/NCT01037153 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036711 Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI https://ClinicalTrials.gov/show/NCT01036711 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036516 PET Assays of Striatal Dopamine Marker in Cocaine Craving https://ClinicalTrials.gov/show/NCT01036516 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036230 The Effects of Expectation on Natural and Drug -Induced Rewards https://ClinicalTrials.gov/show/NCT01036230 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036217 Screening Protocol for the Evaluation of Research Participants https://ClinicalTrials.gov/show/NCT01036217 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036126 Automatic Versus Evaluative Components of Cue Reactivity https://ClinicalTrials.gov/show/NCT01036126 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036074 Reward Processing in Cocaine Addiction https://ClinicalTrials.gov/show/NCT01036074 Completed National Institutes of Health Clinical Center (CC) NA
NCT01035632 Study of Smoking Abstinence https://ClinicalTrials.gov/show/NCT01035632 Completed National Institutes of Health Clinical Center (CC) NA
NCT01030835 Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC) https://ClinicalTrials.gov/show/NCT01030835 Completed National Institutes of Health Clinical Center (CC) NA
NCT01020669 Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development https://ClinicalTrials.gov/show/NCT01020669 Completed National Institutes of Health Clinical Center (CC) NA
NCT01010620 Screening Protocol for Research Participants https://ClinicalTrials.gov/show/NCT01010620 Completed University of Maryland, Baltimore 2019-06-01
NCT00985595 Learning Effective Approaches to Prevention https://ClinicalTrials.gov/show/NCT00985595 Completed The National Center on Addiction and Substance Abuse at Columbia University 2012-03-31
NCT00970372 Dual-Diagnosis and Compulsory Treatment https://ClinicalTrials.gov/show/NCT00970372 Completed Sorlandet Hospital HF 2012-05-31
NCT00882648 The Effect of Fetal Gender on Maternal Substance Abuse Treatment https://ClinicalTrials.gov/show/NCT00882648 Completed Johns Hopkins University 2010-09-30
NCT01253993 Impaired Decision-making in Adolescents https://ClinicalTrials.gov/show/NCT01253993 Completed UMC Utrecht 2007-06-30
NCT01572441 Parent-Adolescent Interactions and Adolescent Development https://ClinicalTrials.gov/show/NCT01572441 Completed George Mason University 2018-12-01
NCT02564991 Study of Structural Imaging https://ClinicalTrials.gov/show/NCT02564991 Completed National Institutes of Health Clinical Center (CC) 2020-03-18
NCT02963948 A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (“CDE-EHR-PC” Study), Phase 3 https://ClinicalTrials.gov/show/NCT02963948 Completed NYU Langone Health 2019-09-09
NCT03217058 Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care https://ClinicalTrials.gov/show/NCT03217058 Recruiting University of California, San Francisco 2020-08-01
NCT01678833 Understanding Drug Abuse Treatment Outcomes https://ClinicalTrials.gov/show/NCT01678833 Completed National Institutes of Health Clinical Center (CC) NA
NCT04419922 A Digital Smoking Cessation Intervention for Adults With Substance Use Disorder https://ClinicalTrials.gov/show/NCT04419922 Active, not recruiting BrightView LLC 2020-10-01
NCT01037075 Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence https://ClinicalTrials.gov/show/NCT01037075 Completed National Institutes of Health Clinical Center (CC) NA
NCT01035723 Effect of Functional Genetic Polymorphisms on Brain Morphology and Function https://ClinicalTrials.gov/show/NCT01035723 Completed National Institutes of Health Clinical Center (CC) NA
NCT00756353 Survey of Buprenorphine Use Among “Out of Care” Population in France (P04933)(COMPLETED) https://ClinicalTrials.gov/show/NCT00756353 Completed Indivior Inc. 2006-12-31
NCT00751426 Treatment of Hepatitis C in Psychiatric Patients https://ClinicalTrials.gov/show/NCT00751426 Completed Charite University, Berlin, Germany 2002-02-28
NCT00726557 Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261) https://ClinicalTrials.gov/show/NCT00726557 Completed Merck Sharp & Dohme Corp. 2009-01-31
NCT00725608 Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) https://ClinicalTrials.gov/show/NCT00725608 Completed Indivior Inc. 2011-04-30
NCT00723749 Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603) https://ClinicalTrials.gov/show/NCT00723749 Completed Indivior Inc. 2010-12-31
NCT00723697 Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) https://ClinicalTrials.gov/show/NCT00723697 Completed Indivior Inc. 2010-02-28
NCT00690352 Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders https://ClinicalTrials.gov/show/NCT00690352 Completed University of Nebraska 2008-07-06
NCT00593034 Medical Office Intervention for Adolescent Drug Use - Attention Study Supplement https://ClinicalTrials.gov/show/NCT00593034 Completed Boston Children’s Hospital 2008-02-29
NCT00579267 Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) https://ClinicalTrials.gov/show/NCT00579267 Completed University of South Florida 2008-01-31
NCT00538252 Parental Involvement and Children’s Extra-Familial Contexts https://ClinicalTrials.gov/show/NCT00538252 Completed University of Pittsburgh 2012-04-30
NCT00522626 Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment https://ClinicalTrials.gov/show/NCT00522626 Completed Johns Hopkins University 2010-02-28
NCT00491335 HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers https://ClinicalTrials.gov/show/NCT00491335 Completed National Institutes of Health Clinical Center (CC) NA
NCT00473993 Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland https://ClinicalTrials.gov/show/NCT00473993 Completed Seidenberg, Arztpraxis A., M.D. NA
NCT00471042 Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care https://ClinicalTrials.gov/show/NCT00471042 Completed New York State Psychiatric Institute 2008-08-31
NCT00439049 Substance Abuse Pre-Treatment Screening Study https://ClinicalTrials.gov/show/NCT00439049 Recruiting The University of Texas Health Science Center, Houston 2021-06-30
NCT00431847 Regional Anesthesia Military Battlefield Pain Outcomes Study https://ClinicalTrials.gov/show/NCT00431847 Completed VA Office of Research and Development 2013-09-30
NCT00247819 The Genetic Basis for Vulnerability to Substance Abuse https://ClinicalTrials.gov/show/NCT00247819 Completed National Institute on Drug Abuse (NIDA) 2006-02-28
NCT00217997 Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals https://ClinicalTrials.gov/show/NCT00217997 Completed The University of Texas Health Science Center, Houston 2013-01-31
NCT00198861 Neurobehavioral Model of HIV in Injection Drug Users https://ClinicalTrials.gov/show/NCT00198861 Completed The City College of New York 2015-03-31
NCT00184184 Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients https://ClinicalTrials.gov/show/NCT00184184 Completed Norwegian University of Science and Technology 2005-06-30
NCT00059540 The Maternal Lifestyle Study (MLS) https://ClinicalTrials.gov/show/NCT00059540 Completed NICHD Neonatal Research Network 1995-03-31
NCT00797095 Health Behaviors in School-age Children: 2009-2010 https://ClinicalTrials.gov/show/NCT00797095 Completed National Institutes of Health Clinical Center (CC) NA
NCT00047866 Brain Function in Response to Motivational Stimuli https://ClinicalTrials.gov/show/NCT00047866 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005765 Behavioral Economics of Human Drug Self-Administration https://ClinicalTrials.gov/show/NCT00005765 Completed National Center for Research Resources (NCRR) NA
NCT00000265 Subjective Effects of Nitrous Oxide in Dental Patients - 17 https://ClinicalTrials.gov/show/NCT00000265 Completed University of Chicago 2002-01-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03220373 Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients https://ClinicalTrials.gov/show/NCT03220373 Active, not recruiting Oslo University Hospital 2029-12-31
NCT02942979 Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking https://ClinicalTrials.gov/show/NCT02942979 Active, not recruiting VA Office of Research and Development 2020-06-30
NCT04336605 Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents https://ClinicalTrials.gov/show/NCT04336605 Active, not recruiting Norwegian Center for Violence and Traumatic Stress Studies 2023-01-31
NCT04256720 The Multi-Ethnic Lifestyle Study https://ClinicalTrials.gov/show/NCT04256720 Recruiting University of Leicester 2023-11-01
NCT03923374 Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes https://ClinicalTrials.gov/show/NCT03923374 Recruiting Indiana University 2023-06-30
NCT03713983 Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder https://ClinicalTrials.gov/show/NCT03713983 Recruiting Karolinska Institutet 2029-12-31
NCT03985163 Patient Reported Outcomes for Opioid Use Disorder https://ClinicalTrials.gov/show/NCT03985163 Completed Yale University 2020-02-16